Takahiro Kubota
Overview
Explore the profile of Takahiro Kubota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki S, Uchiyama K, Motoi Y, Yoshii Y, Inoue Y, Kubota T, et al.
BMC Gastroenterol
. 2023 Jul;
23(1):239.
PMID: 37454061
Background: Thiopurines continue to play an important role in the treatment of inflammatory bowel disease (IBD). It is well known that thiopurines can cause several adverse reactions. Especially, hematopoietic toxicity...
2.
Yoshida R, Yamana H, Hayashi M, Yasuda E, Shibayama Y, Hirose Y, et al.
J Interferon Cytokine Res
. 2021 Sep;
41(9):310-318.
PMID: 34543129
Graft-versus-host disease (GVHD) is a physiological response of the graft to allogeneic hosts. However, the effector cells, affected organ(s), and cytokines in the GVHD remain controversially discussed, without having determined...
3.
Ohno T, Kubota T, Yano M, Fujiwara Y, Araki F
Phys Med
. 2021 May;
86:19-30.
PMID: 34049117
The aim of this study is to evaluate the dosimetric impact of gadolinium contrast medium (Gadovist) in a transverse MR-Linac system using Monte Carlo methods. The dose distributions were calculated...
4.
Osana S, Kitajima Y, Suzuki N, Nunomiya A, Takada H, Kubota T, et al.
J Cell Physiol
. 2020 Dec;
236(7):5293-5305.
PMID: 33378552
The ubiquitin-proteasome system is a major protein degradation pathway in the cell. Proteasomes produce several peptides that are rapidly degraded to free amino acids by intracellular aminopeptidases. Our previous studies...
5.
Ohno T, Araki F, Anami N, Kubota T, Yano M, Ito S
Phys Med
. 2020 Oct;
80:65-74.
PMID: 33120329
Purpose: This study investigated the impact of lung density on the isolated lung tumor dose for volumetric modulated arc therapy (VMAT) in an inline magnetic resonance linear accelerator (MR-Linac) using...
6.
Kubota T, Araki F, Ohno T
Phys Med
. 2020 May;
74:100-109.
PMID: 32450541
Purpose: This study aims to investigate the impact of the cavity on the sinus wall dose by comparing dose distributions with and without the sinus under magnetic fields using Monte...
7.
Yoshida R, Maeda S, Tashiro-Yamaji J, Yasuda E, Shibayama Y, Hirose Y, et al.
J Interferon Cytokine Res
. 2020 Feb;
40(4):207-217.
PMID: 32069165
Organ, skin, or cell allografts are acutely rejected from normal mice, whereas vascularized organ allografts, but not allografted Meth A cells, are rejected from interferon-γ (IFN-γ)-deficient mice. Here we explored...
8.
Motoi Y, Ito Z, Suzuki S, Takami S, Matsuo K, Sato M, et al.
Drug Discov Ther
. 2020 Jan;
13(6):354-359.
PMID: 31956234
Crohn's disease (CD) development is thought to involve genetic factors related to immune response as well as environmental factors, such as intestinal bacteria and diet, though no clear cause has...
9.
Kubota T, Araki F, Ohno T
Med Dosim
. 2019 Nov;
45(2):179-185.
PMID: 31740043
We investigated the impact of the transverse magnetic fields of 0.35 T and 1.5 T on the dose distributions for a 6 MV beam, by using a thorax phantom with...
10.
Kubota T, Araki F, Ohno T
Phys Med
. 2019 Apr;
59:100-106.
PMID: 30928057
The purpose of this study is to investigate the impact of inline magnetic field on dose distribution for volumetric modulated arc therapy (VMAT) in lung tumors located at the chest...